Conditional Müller Cell Ablation Causes Independent Neuronal and Vascular Pathologies in a Novel Transgenic Model

Müller cells are the major glia of the retina that serve numerous functions essential to retinal homeostasis, yet the contribution of Müller glial dysfunction to retinal diseases remains largely unknown. We have developed a transgenic model using a portion of the regulatory region of the retinaldehyde binding protein 1 gene for conditional Müller cell ablation and the consequences of primary Müller cell dysfunction have been studied in adult mice. We found that selective ablation of Müller cells led to photoreceptor apoptosis, vascular telangiectasis, blood–retinal barrier breakdown and, later, intraretinal neovascularization. These changes were accompanied by impaired retinal function and an imbalance between vascular endothelial growth factor-A (VEGF-A) and pigment epithelium-derived factor. Intravitreal injection of ciliary neurotrophic factor inhibited photoreceptor injury but had no effect on the vasculopathy. Conversely, inhibition of VEGF-A activity attenuated vascular leak but did not protect photoreceptors. Our findings show that Müller glial deficiency may be an important upstream cause of retinal neuronal and vascular pathologies in retinal diseases. Combined neuroprotective and anti-angiogenic therapies may be required to treat Müller cell deficiency in retinal diseases and in other parts of the CNS associated with glial dysfunction.

[1]  V. Mohan,et al.  Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy. , 2012, Journal of diabetes and its complications.

[2]  Mingyuan Wu,et al.  Oxidative and endoplasmic reticulum stresses mediate apoptosis induced by modified LDL in human retinal Müller cells. , 2012, Investigative ophthalmology & visual science.

[3]  J. Schulz,et al.  Targeted Ablation of Oligodendrocytes Triggers Axonal Damage , 2011, PloS one.

[4]  A. Tsujikawa,et al.  High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy. , 2011, Investigative ophthalmology & visual science.

[5]  George A. Williams,et al.  Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration , 2011, Proceedings of the National Academy of Sciences.

[6]  T. Gardner,et al.  The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. , 2011, Investigative ophthalmology & visual science.

[7]  David Williams,et al.  Retinal crystals in type 2 idiopathic macular telangiectasia. , 2010, Ophthalmology.

[8]  Julian J. Nussbaum,et al.  Diabetes-induced peroxynitrite impairs the balance of pro-nerve growth factor and nerve growth factor, and causes neurovascular injury , 2011, Diabetologia.

[9]  R. Guymer,et al.  Perifoveal müller cell depletion in a case of macular telangiectasia type 2. , 2010, Ophthalmology.

[10]  T. Langmann,et al.  Microglia in the healthy and degenerating retina: insights from novel mouse models. , 2010, Immunobiology.

[11]  Robert Finger,et al.  Structure-Function Correlation of the Human Central Retina , 2010, PloS one.

[12]  Shiying Li,et al.  Retinal vascular changes after glial disruption in rats , 2009, Journal of neuroscience research.

[13]  N. Osborne,et al.  Cellular signaling and factors involved in Müller cell gliosis: Neuroprotective and detrimental effects , 2009, Progress in Retinal and Eye Research.

[14]  P. Colditz,et al.  S-Adenosyl-l-methionine restores photoreceptor function following acute retinal ischemia , 2009, Visual Neuroscience.

[15]  E. Levine,et al.  Rlbp1 promoter drives robust Müller glial GFP expression in transgenic mice. , 2009, Investigative ophthalmology & visual science.

[16]  T. Terasaki,et al.  Modulation of retinal capillary endothelial cells by Müller glial cell-derived factors , 2009, Molecular vision.

[17]  Philip J Rosenfeld,et al.  BEVACIZUMAB (AVASTIN) THERAPY FOR IDIOPATHIC MACULAR TELANGIECTASIA TYPE II , 2009, Retina.

[18]  D. Ray,et al.  Microvascular P-glycoprotein expression at the blood–brain barrier following focal astrocyte loss and at the fenestrated vasculature of the area postrema , 2007, Brain Research.

[19]  E. Fletcher,et al.  Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy. , 2007, Current pharmaceutical design.

[20]  D. Antonetti,et al.  Vascular permeability in ocular disease and the role of tight junctions , 2007, Angiogenesis.

[21]  W. Hauswirth,et al.  Molecular and cellular alterations induced by sustained expression of ciliary neurotrophic factor in a mouse model of retinitis pigmentosa. , 2007, Investigative ophthalmology & visual science.

[22]  I. Scott,et al.  Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[23]  Peter Wiedemann,et al.  Müller cells in the healthy and diseased retina , 2006, Progress in Retinal and Eye Research.

[24]  D. Guidolin,et al.  Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model , 2006, Diabetologia.

[25]  L. Yannuzzi,et al.  Idiopathic Macular Telangiectasia , 2006, Retina.

[26]  Weng Tao,et al.  Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Capecchi,et al.  Motoneurons and oligodendrocytes are sequentially generated from neural stem cells but do not appear to share common lineage-restricted progenitors in vivo , 2006, Development.

[28]  F. Peale,et al.  Cross-species Vascular Endothelial Growth Factor (VEGF)-blocking Antibodies Completely Inhibit the Growth of Human Tumor Xenografts and Measure the Contribution of Stromal VEGF* , 2006, Journal of Biological Chemistry.

[29]  M. Matsumura,et al.  Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular membranes and polypoidal choroidal vasculopathy , 2004, British Journal of Ophthalmology.

[30]  A. Tsujikawa,et al.  Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes. , 2004, The American journal of pathology.

[31]  D. Guidolin,et al.  A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Matrigel assay in vitro. , 2004, Microvascular research.

[32]  D. Ray,et al.  Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood‐brain barrier in the apparent absence of direct astrocytic contact , 2004, Glia.

[33]  A. Vingrys,et al.  Extraction and modelling of oscillatory potentials , 2004, Documenta Ophthalmologica.

[34]  S. Oliet,et al.  Control of Glutamate Clearance and Synaptic Efficacy by Glial Coverage of Neurons , 2001, Science.

[35]  K. Valter,et al.  Cellular and subcellular patterns of expression of bFGF and CNTF in the normal and light stressed adult rat retina. , 2001, Experimental eye research.

[36]  T. Gardner,et al.  Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. , 2000, Investigative ophthalmology & visual science.

[37]  Michael A. Dyer,et al.  Control of Müller glial cell proliferation and activation following retinal injury , 2000, Nature Neuroscience.

[38]  M. Dubois‐Dauphin,et al.  Early postnatal Müller cell death leads to retinal but not optic nerve degeneration in NSE-Hu-Bcl-2 transgenic mice , 1999, Neuroscience.

[39]  J. Gass,et al.  Müller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacualr retinoschisis. , 1999, Archives of ophthalmology.

[40]  C. Gravel,et al.  Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse. , 1997, Human gene therapy.

[41]  K. A. Rich,et al.  Effects of Müller cell disruption on mouse photoreceptor cell development. , 1995, Experimental eye research.

[42]  H. Hammes,et al.  Nerve Growth Factor Prevents Both Neuroretinal Programmed Cell Death and Capillary Pathology in Experimental Diabetes , 1995, Molecular medicine.

[43]  T. Mitamura,et al.  Diphtheria Toxin Binds to the Epidermal Growth Factor (EGF)-like Domain of Human Heparin-binding EGF-like Growth Factor/Diphtheria Toxin Receptor and Inhibits Specifically Its Mitogenic Activity (*) , 1995, The Journal of Biological Chemistry.

[44]  B. Blodi,et al.  Idiopathic juxtafoveolar retinal telangiectasis , 1993 .

[45]  M. Lavail,et al.  Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  B. Bonavida,et al.  Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha. , 1992, Journal of immunology.

[47]  I. Maxwell,et al.  Cloning, sequence determination, and expression in transfected cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain , 1987, Molecular and cellular biology.

[48]  J. Gass,et al.  Idiopathic juxtafoveolar retinal telangiectasis. , 1982, Archives of ophthalmology.